Bloomage
Bloomage
Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Bloomage, founded in January, 2000 and headquartered in Jinan, is a hyaluronic acid R&D manufacturer. The founder is Zhao Yan. Listed on the SSE on November 6, 2019, the company's major shareholders are Huaxi Xinyu Investment Co., Ltd., China Life Chengda (Shanghai) Health Industry Equity Investment Center (LP) and Ningxia Yingrui Wuyuan PE Partnership Enterprise (LP). Rivals that have direct and indirect competition with Bloomage include Well, Boai Nky, Pharm Agra, Mylan, etc.
- All
- News
- Analysis
- Research
Briefing Nov 17, 2020 08:04 PM
· Healthcare
Plan to raise $4 billion! Jingdong health runs IPO
Briefing Nov 11, 2020 10:42 AM
· Healthcare
Drug Innovator Asieris Nabs CNY 700 Million Series D
In depth
Briefing Nov 03, 2020 12:06 PM
· Healthcare
HaoYuan Chemexpress Files for IPO on the Star Market
Briefing Oct 16, 2020 04:24 PM
· Healthcare
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
Research
Real Estate, Consumer Discretionary, IndustrialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Consumer Staples, Industrials, FinancialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Apr 26, 2020 03:17 PM
Apr 19, 2020 06:36 PM
Briefing Sep 28, 2020 08:25 PM
· Healthcare
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
Briefing Sep 28, 2020 12:12 PM
· Healthcare
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Briefing Sep 28, 2020 10:49 AM
· Healthcare
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
Briefing Sep 23, 2020 11:37 AM
· Healthcare
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Healthcare
WIM Presents Next 50 in Global Tech: Healthcare
In 2020, as COVID-19 spread around the world, people began to pay more attention to the healthcare industry. The crisis of the pandemic has led directly to significant changes in the healthcare industry across the globe.
Oct 29, 2020 11:00 AM
Briefing Sep 23, 2020 11:11 AM
· Healthcare
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Briefing Sep 22, 2020 12:23 PM
· Healthcare
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
Briefing Sep 18, 2020 10:58 AM
· Healthcare
Biotech IMAB’s In-Process New Drug Enters Clinical Trials
Industrials, Communication, Financials · Analysis
Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.
Oct 20, 2020 07:40 PM
Briefing Sep 15, 2020 12:24 PM
· Healthcare
Antibody Developer Biocytogen Closes Series D+ at CNY 790 Mn
Briefing Sep 14, 2020 06:28 PM
· Healthcare
Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO
Briefing Sep 14, 2020 06:22 PM
· Healthcare
Genor Biopharma Passes the Hearing for Hong Kong IPO
Briefing Sep 04, 2020 11:09 AM
· Healthcare
Changchun BCHT Biotech Records 45.44% Revenue Growth in 1H 2020
See more
Related Companies
EqualOcean Analysis
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
- More Room for the Medical Device Market to Grow in China
- Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.